remoote.app

Work from anywhere. Start here.

Remoote.app

Work from anywhere. Start here.

Free resume builderCompaniesLog in
Home
Companies
Kyverna Therapeutics

Kyverna Therapeutics

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

101-250 employees
Biotechnology
Public Company
WebsiteLinkedInEmailShareTweet
BiotechnologyTherapeuticsLife Science

Hybrid Work Model

This company offers a hybrid work model combining remote and office work.

Open Positions11

West Coast RemoteFull-TimeBiopharmaceuticalPosted
Sr. Director, Marketing Promotions
  • Define and own the global promotional strategy, ensuring alignment with brand goals and patient needs.
  • Manage budget, agency of record, and key agency partnerships to deliver commercial resources.
  • Develop promotional materials across digital, field-based, congress, and non-personal channels.
  • Create the commercial launch Plan of Action (POA) and provide guidance to field sales teams.
  • Collaborate with Medical Affairs, Market Access, and HEOR to ensure compliant and aligned messaging.
  • Lead promotional readiness for product launches and oversee lifecycle management strategies.
  • Establish and manage efficient Promotional Review Committee (PRC) processes.
  • Build, develop, and mentor a high-performing marketing promotions team.
Project ManagementCross-functional Team LeadershipFinancial Management
Apply
Showing 1 of 11 positions

About Kyverna Therapeutics

Kyverna Therapeutics is pioneering a new class of treatments to potentially cure serious autoimmune diseases. We combine advanced T-cell engineering and synthetic biology to target the root cause of inflammatory diseases. Our platform focuses on developing CAR T-cell therapies, including KYV-101 in Phase 2 trials for multiple autoimmune conditions. Kyverna has raised $322 million and became public in February 2024, trading on Nasdaq as KYTX.

How We Work

We embrace a patient-centered approach, guided by core values like 'Stay True to Why' and 'Collaborate to Accelerate'. Our flexible work environment includes remote and hybrid options. We foster an open, supportive, and inclusive culture that encourages continuous learning and growth for our team of 100-250 employees.

Innovation at Kyverna

Our therapeutic platform combines cutting-edge T-cell engineering and synthetic biology. We suppress and eliminate autoreactive immune cells to treat inflammatory diseases. Our pipeline includes Mivocabtagene autoleucel (miv-cel, KYV-101), KYV-102, and KYV-201. These investigational CAR T-cell therapies aim to transform autoimmune disease treatment. We are developing solutions like Ingenui-T, a rapid manufacturing process that uses whole blood for cell therapy candidates.

Why Join Us

  • Pioneer novel CAR T-cell therapies to cure serious autoimmune diseases.
  • Contribute to a public company with $322 million in funding, ensuring significant impact.
  • Work in a flexible, remote-first environment with a focus on collaboration and innovation.
  • Shape the future of medicine in a rapidly growing biotechnology field.
  • Receive a robust benefits package, including equity grants and performance bonuses.

Benefits & Perks

  • Unlimited Flexible PTO, including Holidays and Winter Shutdown
  • Generous company-subsidized medical, dental, and vision insurance
  • 401(k) retirement with company match
  • Equity grants and performance bonuses
  • Parental Leave and Employee Assistance Program (EAP)
  • Commuter benefits, onsite gym, legal protection, and discount programs

Tech Stack

widgets

Similar Companies

Orchard Therapeutics

101-250 employees · Biotechnology

Oruka Therapeutics

101-250 employees · Biotechnology